Evidence map›Paper›PMID 31257069›Full record

ArticleOphthalmology. Retina2019

Signal Strength Reduction Effects in OCT Angiography.

Jeffrey J Yu, Acner Camino, Liang Liu, Xinbo Zhang, Jie Wang, Simon S Gao, Yali Jia, David Huang

Open access · greenAbstract read
In one paragraph

Article in Ophthalmology. Retina, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Factors affecting optical coherence tomography angiography signal strength index in patients receiving intravitreal injection treatment.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jeffrey J YuCasey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Acner CaminoCasey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Liang LiuCasey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Xinbo ZhangCasey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Jie WangCasey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Simon S GaoCasey Eye Institute, Oregon Health & Science University, Portland, Oregon.
Yali JiaCasey Eye Institute, Oregon Health & Science University, Portland, Oregon.
David HuangCasey Eye Institute, Oregon Health & Science University, Portland, Oregon. Electronic address: huangd@ohsu.edu.
Oregon Health & Science University · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
Functional and Structural Optical Coherence Tomography for GlaucomaR01EY023285 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI David Huang · 2013 to 2026
$8.8M
OCT Angiography for Neovascular Age-related Macular DegenerationR01EY024544 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Steven T Bailey, Yali Jia · 2014 to 2026
$6.2M
Translational Vision Science Research at Oregon Health & Science UniversityT32EY023211 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Yali Jia, Kate E Keller · 2013 to 2026
$2.4M
Wide-field and projection-resolved optical coherence tomography angiography in diabetic retinopathyR01EY027833 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HWANG, THOMAS, JIA, YALI · 2017 to 2020
$1.8M
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY023285NEI NIH HHS R01 EY024544NEI NIH HHS R01 EY027833NEI NIH HHS T32 EY023211
6 · The paper itself

Abstract

purposeTo elucidate the relationship between vessel density (VD) measurements and signal strength in OCT angiography (OCTA).

designCross-sectional study.

participantsHealthy volunteers.

methodsOCT angiography images obtained from healthy volunteers were analyzed to demonstrate the relationship between signal strength index (SSI) and VD. Experiments were performed to determine the effects of signal strength reduction on VD measurements on the Optovue/AngioVue (Optovue, Inc, Fremont, CA) and Cirrus/AngioPlex OCTA (Carl Zeiss Meditec, Inc, Dublin, CA) systems. Signal strength reduction was generated by either neutral density filters (NDFs) or defocus.

main outcome measuresRegression analysis of signal strength effects on VD.

resultsVessel density decreased linearly with signal strength with high statistical significance on both OCTA systems tested and for all analyzed sources of variation in signal strength. The slope of VD versus SSI was greatest when signal strength was adjusted by NDFs, followed by defocus, interscan difference, interindividual variation, and left-right eye difference. Multivariate analysis revealed that both SSI and age had a significant effect on the interindividual variation in VD.

conclusionsVessel density measurements using OCTA were affected significantly by OCT signal strengths on 2 OCTA platforms. Investigators should exercise caution when interpreting VD data from OCTA scans. Quantification algorithms for OCTA should ideally remove the signal strength bias.

Indexed as

AlgorithmsArtifactsAdultAgedAged, 80 and overCross-Sectional StudiesFemaleFluorescein AngiographyFundus OculiHealthy VolunteersHumansMaleMiddle AgedRetinal VesselsTomography, Optical Coherence

Identifiers

PMID31257069
PMCPMC6778507
OpenAlexW2944372562

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.